Madrid, 26 Aug (EFE).-the Nobel Prize in chemistry 2009, American Thomas Steitz, denounced the fact that the pharmaceutical laboratories not investigated in effective antibiotics today in Madrid and added that “they do not want people to cure”.
Prefer to focus the business on medications is necessary to take over “the life”, said Steitz, who believes that “many big drug companies have closed their research on antibiotics because these cured people.
“
Researcher of the Institute doctor Howard Hughes of the American Yale University, Steitz attends the International Congress of Crystallography (study of the ordered structure of the atoms in crystals of nature) in Madrid.
In the case of tuberculosis, Steitz has ascertained the operation to be followed by a new antibiotic to combat strains resistant to the disease arising mainly in the South of Africa.
Scientist said in a press conference that the development of this precise medicine a great economic investment and the collaboration of a pharmaceutical to advance in the research.
“Us is very difficult to find a pharmacist who wants to work with us, because for these companies sell antibiotics in countries as South Africa does not only generate money and they prefer to invest in drugs for life”.
For the time being, according to Steitz, these new antibiotics are “just a dream, hope, unless someone is willing to finance the work”.
Steitz and Spaniards Enrique Gutiérrez-Puebla and Martin M. Ripoll, Consejo Superior de Investigaciones CientÃficas (CSIC), today made an appeal to countries that invest more in science.
Scientists believe that the resistance of bacteria to antibiotics will be necessary to continue investigating “indefinitely”.
The prize Nobel for Chemistry Thomas a. Steitz, whose investigations have provided clarity on the chemistry of the Union of antibiotics and Ribosomes and mutations causing resistance to these drugs during his speech at a meeting with journalists. EFE
